CM
Therapeutic Areas
Phio Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| PH-762 | Cutaneous Squamous Cell Carcinoma (cSCC), Stage IV Melanoma, Stage IV Merkel Cell Carcinoma | Phase 1b |
| PH-894 | Stage IV Melanoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Hepatocellular Carcinoma (HCC), HPV-related cSCC, Cervical Cancer, Prostate Cancer | Preclinical |
| Synergies with Antibodies | Not Specified | Research |
| Synergies with Cell Therapies | Not Specified | Research |
| PH-231 | Not Specified (Melanin production) | Research |